CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 133 filers reported holding CTI BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $69,607 | -56.2% | 16,573 | -37.4% | 0.00% | – |
| Q4 2022 | $159,007 | -57.3% | 26,457 | -58.6% | 0.00% | -100.0% |
| Q3 2022 | $372,000 | -61.6% | 63,851 | -60.7% | 0.00% | -50.0% |
| Q2 2022 | $970,000 | +64.1% | 162,435 | +28.4% | 0.00% | +100.0% |
| Q1 2022 | $591,000 | -27.4% | 126,555 | -61.4% | 0.00% | 0.0% |
| Q4 2021 | $814,000 | +614.0% | 328,245 | +752.7% | 0.00% | – |
| Q3 2021 | $114,000 | +60.6% | 38,495 | +17.2% | 0.00% | – |
| Q3 2020 | $71,000 | +545.5% | 32,852 | +236.9% | 0.00% | – |
| Q2 2020 | $11,000 | -21.4% | 9,752 | -30.1% | 0.00% | – |
| Q1 2019 | $14,000 | +100.0% | 13,957 | +37.4% | 0.00% | – |
| Q4 2018 | $7,000 | -56.2% | 10,157 | +37.1% | 0.00% | – |
| Q3 2018 | $16,000 | – | 7,407 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 6,535,674 | $27,449,831 | 9.21% |
| Bleichroeder LP | 3,893,730 | $16,353,666 | 3.49% |
| AIGH Capital Management LLC | 2,100,000 | $8,820,000 | 3.25% |
| Ally Bridge Group (NY) LLC | 550,000 | $2,310,000 | 3.03% |
| Ghost Tree Capital, LLC | 2,000,000 | $8,400,000 | 2.48% |
| Bain Capital Life Sciences Investors, LLC | 4,702,996 | $19,753 | 2.47% |
| Altium Capital Management LP | 850,000 | $3,570,000 | 1.98% |
| Parkman Healthcare Partners LLC | 1,753,630 | $7,365,246 | 1.60% |
| BVF INC/IL | 8,813,021 | $37,014,688 | 1.35% |
| Sio Capital Management, LLC | 526,239 | $2,210,204 | 1.09% |